DUBLIN--(BUSINESS WIRE)--The "Innovations Transforming the Global Healthcare IT, Biomarker, Biologics, and Small Molecule Landscape" report has been added to ResearchAndMarkets.com's offering.
This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) provides technological insights across 26 global healthcare innovations.
The technologies analyzed include advances in digital health, biologics, small molecules, medical imaging, dental caries and precision oncology platforms. The TOE also covers application and megatrends impact, apart from exclusive analyst insights for each innovation.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Companies featured:
- Capsule Technologies
- GenXComm
- Dell Technologies
- BlueBee
- Numares Health
- Entasis Therapeutics Holdings Inc.
- CALCiViS Ltd.
- Congenica Ltd.
- Previvo Genetics LLC
- Gedea Biotech AB
- LabGenius Ltd.
- Nanoform Finland Oy
- OSSIO Inc.
- Protalix Biotherapeutics Inc.
- Novo Nordisk
- Locus Biosciences
- NanoString Technologies, Inc.
- bioMrieux
- ReNeuron
- Stealth BioTherapeutics
- Akcea Therapeutics
- Boston Pharmaceuticals
- Arcellx
- Reata Pharmaceuticals
- Stanford University
- Ziopharm Oncology
For more information about this report visit https://www.researchandmarkets.com/r/98ey4z
